Women's Risk Perceptions and Willingness to Engage in Risk-Reducing Interventions for the Prevention of Obesity-Related Endometrial Cancer

被引:10
作者
Derbyshire, Abigail E. [1 ]
MacKintosh, Michelle L. [1 ]
Pritchard, Christina M. [1 ]
Pontula, Arya [2 ]
Ammori, Basil J. [3 ,4 ]
Syed, Akheel A. [4 ,5 ]
Beeken, Rebecca J. [6 ]
Crosbie, Emma J. [1 ,2 ]
机构
[1] Manchester Univ NHS Fdn Trust, Dept Obstet & Gynaecol, Manchester, Lancs, England
[2] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[3] Salford Royal NHS Fdn Trust, Dept Surg, Salford, Lancs, England
[4] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England
[5] Salford Royal NHS Fdn Trust, Dept Obes Med Diabet & Endocrinol, Salford, Lancs, England
[6] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England
关键词
endometrial cancer; obesity; risk reducing interventions; weight loss; exercise; chemoprevention; levonorgestrel-releasing intrauterine system; metformin; WEIGHT-LOSS; KNOWLEDGE; METAANALYSIS;
D O I
10.2147/IJWH.S326417
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Endometrial cancer rates are rising in parallel with the global obesity epidemic. Our aim was to assess the willingness of women at greatest risk of obesity-related endometrial cancer to engage with risk-reducing strategies and establish perceived barriers that may preclude their participation in a randomized controlled trial of primary endometrial cancer prevention. Materials and Methods: Women attending gynecology, obesity and sleep apnea clinics in Manchester Academic Health Sciences Centre-affiliated hospitals with obesity classes II (BMI 35-39.9kg/m(2)) and III (BMI >= 40kg/m(2)) were invited to participate in a cross-sectional survey. We asked women about their perceived risk, knowledge of risk factors and willingness to engage with endometrial cancer risk-reducing interventions. Results: Seventy-four women with a median age of 51 years (range 22-73) and BMI of 47kg/m(2) (range 34-81) took part in the study. Two-thirds (65.6%) knew that obesity was a risk factor for endometrial cancer but few were able to recall other major risk factors. Just over half (53.5%) perceived their risk of developing endometrial cancer to be higher than average. Women were prepared to lose weight (94%), eat healthily (91%), exercise more (87%), take a pill every day (74%) or receive an intra-uterine device (49%) for primary endometrial cancer prevention. Perceived barriers included cost, forgetting, willpower, finding time, physical fitness, social anxiety, possible side effects and previous bad experiences. Conclusion: Women at highest risk of obesity-related endometrial cancer may not always appreciate their susceptibility. However, willingness to engage in risk-reducing strategies suggests recruitment to a randomized controlled trial for primary endometrial cancer prevention could be feasible.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 59 条
[1]   Medical and surgical management of obesity and diabetes: what's new? [J].
Ammori, B. J. ;
Skarulis, M. C. ;
Soran, H. ;
Syed, A. A. ;
Eledrisi, M. ;
Malik, R. A. .
DIABETIC MEDICINE, 2020, 37 (02) :203-210
[2]   Benefits and Risks of Bariatric Surgery in Adults A Review [J].
Arterburn, David E. ;
Telem, Dana A. ;
Kushner, Robert F. ;
Courcoulas, Anita P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (09) :879-887
[3]   Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET): pragmatic randomised controlled trial [J].
Astbury, Nerys M. ;
Aveyard, Paul ;
Nickless, Alecia ;
Hood, Kathryn ;
Corfield, Kate ;
Lowe, Rebecca ;
Jebb, Susan A. .
BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
[4]   Obesity and cancer risk: Emerging biological mechanisms and perspectives [J].
Avgerinos, Konstantinos, I ;
Spyrou, Nikolaos ;
Mantzoros, Christos S. ;
Dalamaga, Maria .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 92 :121-135
[5]   Association between genetic polymorphisms and endometrial cancer risk: a systematic review [J].
Bafligil, Cemsel ;
Thompson, Deborah J. ;
Lophatananon, Artitaya ;
Smith, Miriam J. ;
Ryan, Neil A. J. ;
Naqvi, Anie ;
Evans, D. Gareth ;
Crosbie, Emma J. .
JOURNAL OF MEDICAL GENETICS, 2020, 57 (09) :591-600
[6]   Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods [J].
Bahamondes, Luis ;
Bahamondes, M. Valeria ;
Shulman, Lee P. .
HUMAN REPRODUCTION UPDATE, 2015, 21 (05) :640-651
[7]   Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium [J].
Barr, Chloe E. ;
Ryan, Neil A. J. ;
Derbyshire, A. E. ;
Wan, Y. Louise ;
MacKintosh, Michelle L. ;
McVey, Rhona J. ;
Bolton, James ;
Fitzgerald, Cheryl ;
Awad, Dina ;
Slade, Richard J. ;
Syed, Akheel A. ;
Ammori, Basil J. ;
Crosbie, Emma J. .
CANCER PREVENTION RESEARCH, 2021, 14 (11) :1041-1050
[8]   Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life-a prospective study [J].
Bischoff, S. C. ;
Damms-Machado, A. ;
Betz, C. ;
Herpertz, S. ;
Legenbauer, T. ;
Loew, T. ;
Wechsler, J. G. ;
Bischoff, G. ;
Austel, A. ;
Ellrott, T. .
INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (04) :614-624
[9]   Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[10]  
Cancer Research UK, 2015, UT CANC SURV STAT